A bunch of stuff, thoughts, ramblings, etc.. Newer

New Post Public Reply Private Reply Replies (1) Message Board
joey68
A bunch of stuff, thoughts, ramblings, etc..

Newer stuff
Go here
https://www.euroscan.org/
search ‘wavstat4’
click ‘WavSTAT4 Optical Biopsy System® for colorectal cancer diagnosis’ link
Notice it was just updated 7 months ago
Notice it says Stage of EAA: Assessment Complete
To read the entire thing, you would have to ‘Download Attachments’

Also a few notes..
Someone else just mentioned this yesterday (nice job), but its good to reiterate:
Don’t forget, SCIE has developed a “rack-mounted” version of the Wavstat4 which is smaller and more compact. This version was “met with overwhelming acceptance by our customers,” said Michael Oliver

The best part about this PR is that it says the WavSTAT works with ALL major manufacturers endoscopes. As was mentioned in a previous post, talking about a buyout right now is ridiculous, but knowing SCIEs technology is cross-compatible with the competitors, it would make it easier for an acquisition/buyout to occur. My opinion is that any buyout would come from PENTAX seeing they already have the infrastructure set up for the WavSTAT.

Important:
The WavSTAT4 can be seen on PENTAX's website for spain, the united kingdom, Germany, Italy and another country I cant remember right now. But the wavstat4 is NOT shown on the USA PENTAX website because just like SCIE said, they are selling the product to Europe FIRST and then America. once we see the wavstat4 showing up on the USA website, we'll know something big is about to happen.

In addition, information from the December 2015 PR:
SAN DIEGO, CA--(Marketwired - December 08, 2015) - SpectraScience, Inc. (OTCQB: SCIE),announced today that in a presentation at United European Gastroenterology Week (UEGW) by Dr. Timo Rath of the University of Erlangen, the WavSTAT4 Optical Biopsy System(R) was once again found to exceed the clinical guidelines adopted by EU and US medical societies for the diagnosis of small and diminutive colorectal polyps during screening colonoscopies.

From what I gather, the company is well beyond figuring out whether or not the product works. The natural next step would be to sell the product, which SCIE has been working on by setting up their distribution channels. Obviously, these channels aren’t built over night, and can take years. Fortunately, we are now in the 4th year of setting these up, which is why it makes sense (at least to me) that we should be seeing sales soon. The great thing about SCIE, is unlike many other pennystocks, SCIE has a product. Not only that, the product has been tested for several years and is shown to work effectively. Not only that, its been used countless times in trials around the world. We have distribution centers in Europe and Spain (PENTAX in Spain bought out SIMMEDICA years ago. This is mentioned in several previous posts if youre interested. Theres even a picture of the building with the words PENTAX/SIMMEDICA on the front).

Also..

Years ago, there was so much interest in the WavSTAT that SCIE had to cancel their conference in order to accommodate more people.

Back in 2009, investors were willing to pay .45 cents and more per share. I see this happening again with the right news. Its important for me to remember that many people out there have a LOT more money than I do, and it is not a problem for them to purchase shares at $2 or more each. Many investors refuse to buy pennystocks in the first place.

I believe the time has come for investors to read news of sales; hopefully in this 10K on march 30th, but if not, within this year. Even if there are no sales, I personally see no reason why the PPS cant continue to climb because I am sure the company will continue to release PRs as they have done since the beginning.

Its undeniable the chart’s trend is moving up. The Elder Impulse, yet again, added yet another green day, despite having red days in the past. The previous post shows a continual upward trend as well.

Investor sentiment is growing, the naysayers are showing up more and more each day, SCIE just acquired another company which means some form of PR will come out about the progress.

We had the Arab conference where more than likely SCIE made business connections (the picture of the three people at the conference shows 2 people who were possibly interested buyers).

All of this and more we know about, which makes me wonder about the things we don’t know about yet.
Just last year, SCIE entered into a distribution agreement with JAGWorldwide to introduce the Wavstat to the middle east. We have our distribution with PENTAX as well.
Currently underway, SCIE is working on making the wavstat compatible for detecting bladder lesions which opens whole new doors of possibilities.

We know the Wavstat has been in europe since 2012 (and probably before this). Despite what naysayers may want us to think, 4 years is not that long ago for the medical field. Would you want something up your buttock that was tested for only a year? I know I wouldn’t.

We know without a doubt, SCIE has had sales, and not tiny sales like many other pennystocks ranging from $800 to $50,000. SCIE had sales of $310,000 and $150,000 in the past. Reasons for the decline in sales includes the need for funding, which they worked on, ongoing trials, waiting on PMA approvals, etc etc.

Sales and profits are the goals and we cant have either unless the company first builds a strong foundation. I believe this foundation has been set and it is now time to move upward.

As for any debt SCIE may still have, I believe within the next 3 years this company will be debt free; or if they have debt, it will be good debt which means 'it takes money to make money'. in all, I believe the sales of the WavSTAT4 in the long run is going to obliterate their debt. Seeing they made $310,000 profit back in 2012, this number could probably be quadrupled or more when sales begin again.

Not investment advice. Go talk to your investment advisor.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensuring Your Radon Mitigation System Stays Effective

Updated Category News Views 2

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Continue Reading
AI Ambassadors Rethink Arbitration's Future

Updated Category News Views 5

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 3

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
Kobold Press Explores Roleplaying as Literacy Tool

Updated Category News Views 5

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Continue Reading
Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 6

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
FOSSI Opens 2027 Applications for Future STEM Leaders

Updated Category News Views 3

Paving Pathways in the Chemical Industry There's something brewing that's got me eyeing the future with cautious optimism, and it doesn't involve hedge funds or earnings reports. It's the Future of STEM Scholars Initiative (FOSSI) playing its cards just right, planting seeds for tomorrow's innovators. This puppy opened the gates for 2027 applications, and for young brains...

Continue Reading
Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

Updated Category News Views 7

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Continue Reading
Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 2

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Fintech: The New Age of Payments and AI

Updated Category News Views 317

Understanding the Future of Global Payments The world of global payments is on the brink of immense transformation, driven by agentic AI, digital currencies, and real-time transaction capabilities. These innovations are setting the stage for the payment industry to reach an unprecedented forecasted revenue of $2.4 trillion. This significant change, as outlined in recent...

Continue Reading
Waymo Hits Major Milestone: 450,000 Weekly Robotaxi Rides

Updated Category News Views 230

Waymo Achieves 450,000 Weekly Rides Alphabet Inc.'s self-driving company Waymo has recently made headlines by achieving a remarkable milestone of 450,000 weekly rides. This figure demonstrates the rapid progress Waymo is making in the autonomous vehicle sector, showcasing its leadership in the robotaxi segment. The Surge in Robotaxi Utilization This impressive leap from...

Continue Reading
Crown Aesthetics Partners with Cavendish Clinics for SkinPen Innovation

Updated Category News Views 318

Crown Aesthetics Empowers Cavendish Clinics with SkinPen Precision Crown Aesthetics, a subsidiary of Crown Laboratories and a leader in the aesthetics industry, is excited to announce an innovative partnership with Cavendish Clinics. This collaboration brings the award-winning SkinPen® Precision microneedling system to Cavendish Clinics, a renowned aesthetic clinic in...

Continue Reading
MarketsandMarkets Unveils AI-Driven Hub to Boost B2B Growth

Updated Category News Views 108

Introducing the Revenue Intelligence Hub MarketsandMarkets has launched an innovative Revenue Intelligence Hub designed to enhance B2B growth strategies. This state-of-the-art platform, featuring the advanced SalesPlay revenue intelligence tool, provides essential advantages for sales teams aiming for success by revealing revenue opportunities before they become apparent...

Continue Reading
Clay Cooley Auto Group Expands with New Ford Dealership

Updated Category News Views 563

Clay Cooley Auto Group Expands Its Reach with New Dealership Clay Cooley Auto Group is thrilled to announce that it has acquired Don Davis Ford, which will now operate under the name Clay Cooley Ford. This addition is a major leap forward for the group, signaling a commitment to enhance automotive services in the region. Enhancing the Customer Experience Focus on Quality...

Continue Reading